Anvisa registra caneta para diabetes que combina insulina e semaglutida
Produto é o primeiro a associar dose fixa de insulina basal e agonista do receptor de GLP-1 em administração semanal
This is an extract. The publication continues at the source.
Read the original at the source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-registra-caneta-para-diabetes-que-combina-insulina-e-semaglutida
Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
- Official source
- https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
- Imported
- October 04, 2026 07:33
- Versions
- 1 recorded
- Identity
-
b68ec64aaea94fcc80cae98e95e4c73b